通过公私合作提高制药公司的研发效率：创新药物倡议的经验 - Suppr

Suppr

超能文献

Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.

作者信息

Laverty Hugh, Gunn Magda, Goldman Michel

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2012 Oct;12(5):545-8. doi: 10.1586/erp.12.59. Epub 2012 Nov 8.

DOI:10.1586/erp.12.59

PMID:23136843

Abstract

摘要

相似文献

Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.

Expert Rev Pharmacoecon Outcomes Res. 2012 Oct;12(5):545-8. doi: 10.1586/erp.12.59. Epub 2012 Nov 8.

The innovative medicines initiative: a European response to the innovation challenge.

Clin Pharmacol Ther. 2012 Mar;91(3):418-25. doi: 10.1038/clpt.2011.321. Epub 2012 Feb 8.

Reflections on the Innovative Medicines Initiative.

Nat Rev Drug Discov. 2011 May;10(5):321-2. doi: 10.1038/nrd3434.

Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.

Int J Health Care Finance Econ. 2009 Jun;9(2):169-82. doi: 10.1007/s10754-009-9063-5. Epub 2009 Apr 10.

Open PHACTS: semantic interoperability for drug discovery.

Drug Discov Today. 2012 Nov;17(21-22):1188-98. doi: 10.1016/j.drudis.2012.05.016. Epub 2012 Jun 7.

Intellectual property policies in early-phase research in public-private partnerships.

Nat Biotechnol. 2016 May 6;34(5):504-10. doi: 10.1038/nbt.3562.

Global strategic partnerships in regenerative medicine.

Trends Biotechnol. 2014 Sep;32(9):436-40. doi: 10.1016/j.tibtech.2014.05.007.

Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.

Drug Discov Today. 2012 Nov;17(21-22):1242-8. doi: 10.1016/j.drudis.2012.04.004. Epub 2012 Apr 12.

Competition: Unlikely partnerships.

Nature. 2016 May 12;533(7602):S56-8. doi: 10.1038/533S56a.

Public-private partnership models in France and in Europe.

Therapie. 2006 Jul-Aug;61(4):325-34, 313-23. doi: 10.2515/therapie:2006059.

引用本文的文献

Patient and Public Involvement in Sexual and Reproductive Health: Time to Properly Integrate Citizen's Input into Science.

Int J Environ Res Public Health. 2020 Oct 31;17(21):8048. doi: 10.3390/ijerph17218048.

Fast Screening of Inhibitor Binding/Unbinding Using Novel Software Tool CaverDock.

Front Chem. 2019 Oct 29;7:709. doi: 10.3389/fchem.2019.00709. eCollection 2019.

Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?

J Transl Med. 2018 May 8;16(1):119. doi: 10.1186/s12967-018-1499-2.

The European Lead Factory: A Blueprint for Public-Private Partnerships in Early Drug Discovery.

Front Med (Lausanne). 2017 Jan 19;3:75. doi: 10.3389/fmed.2016.00075. eCollection 2016.

Sustaining Vaccine Confidence in the 21st Century.

Vaccines (Basel). 2013 Jun 24;1(3):204-24. doi: 10.3390/vaccines1030204.

The innovative medicines initiative: a public private partnership model to foster drug discovery.

Comput Struct Biotechnol J. 2013 Nov 27;6:e201303017. doi: 10.5936/csbj.201303017. eCollection 2013.

Drug discovery for autism spectrum disorder: challenges and opportunities.

Nat Rev Drug Discov. 2013 Oct;12(10):777-90. doi: 10.1038/nrd4102.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验